Circular pOlyethylene Drape in preVention of Surgical Site infEction: A Randomized Controlled Trial (COVER)

May 9, 2023 updated by: Hyung Jin Kim, Saint Vincent's Hospital, Korea

Randomized Controlled Trial to Evaluate the Effectiveness and Efficacy of a Sterile Circular Polyethylene Drape Compared to Conventional Surgical Dressing in Prevention of Surgical Site Infection

This study is to evaluate the effectiveness of the plastic ring wound retractor to reduce the rate of surgical site infection in patients who undergo open abdomen surgery for gastrointestinal tract.

Study Overview

Status

Completed

Detailed Description

Participants who are determined to undergo open abdomen surgery will be screening for the eligibility first. If eligible and agreed to participate, each participant will be assigned to either the experimental group or control group based on the electronic randomization. The experimental group will use the plastic ring wound retractor, while the control group will use a conventional surgical pad for wound protection method. Each participant will be blind to the randomization result because he/she will be under general anesthesia. Once the surgery is finished, the patient will be assessed on the surgical wound at postoperative day 1, 7, 14, 30. Two groups will be compared for the surgical wound infection rate.

Study Type

Interventional

Enrollment (Actual)

457

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Seoul, Korea, Republic of
        • Chung-ang University Hospital
      • Seoul, Korea, Republic of, 05278
        • Kyung Hee University Hospital at Gangdong
      • Seoul, Korea, Republic of, 06591
        • Seoul St. Mary's Hospital, The Catholic University of Korea
      • Seoul, Korea, Republic of
        • Eunpyeong ST. Mary's Hospital
      • Seoul, Korea, Republic of
        • Yeouido St. Mary's hospital, The Catholic University of Korea
    • Chonnam
      • Gwangju, Chonnam, Korea, Republic of
        • Chonnam National University Hospital
    • Gangwondo
      • Chuncheon, Gangwondo, Korea, Republic of, 200-704
        • Hallym University Chuncheon Sacred Heart Hospital
    • Gyeonggi-do
      • Goyang-si, Gyeonggi-do, Korea, Republic of, 10444
        • National Health Insurance Service Ilsan Hospital
      • Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620
        • Seoul National University Bundang Hospital
      • Suwon, Gyeonggi-do, Korea, Republic of
        • Ajou University of Hospital
      • Suwon-si, Gyeonggi-do, Korea, Republic of, 442-723
        • St. Vincent's Hospital
      • Uijeongbu-si, Gyeonggi-do, Korea, Republic of, 480-717
        • Ujeongbu St Mary's Hospital, The Catholic University of Korea
    • Gyeongsangbukdo
      • Daegu, Gyeongsangbukdo, Korea, Republic of, 41931
        • Keimyung University Dongsan Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • age older than 18 years or less than 75 years
  • either elective or emergent surgery for upper GI, small intestine, or colorectal disease
  • open laparotomy
  • the patient who agrees to participate in this trial

Exclusion Criteria:

  • concurrent abdominal wall infection
  • open conversion from laparoscopy
  • poor nutritional status, NRS 2002 score 3
  • combined hepatobiliary operation
  • pregnant or breast-feeding state
  • severe immunosuppression

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: O-Trac
The experimental group will use the plastic ring wound retractor for wound protection during the surgery.
the experimental arm will use the plastic ring wound retractor for wound protection.
No Intervention: Surgical pad
The control group will use a conventional surgical pad for wound protection during the surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of surgical wound infection
Time Frame: within 30 days postoperative
The rate of surgical wound infection will be monitored for each group.
within 30 days postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: HyungJin Kim, MD, Eunpyeong St. Mary's Hospital, The Catholic University of Korea

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 12, 2017

Primary Completion (Actual)

July 11, 2022

Study Completion (Actual)

September 30, 2022

Study Registration Dates

First Submitted

May 26, 2017

First Submitted That Met QC Criteria

May 26, 2017

First Posted (Actual)

May 31, 2017

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 9, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Wound Infection

Clinical Trials on use of plastic ring wound retractor

3
Subscribe